China’s blood product market size is about 24 billion Yuan, HSA dominates but factor VIII was 6.3 %

The Chinese blood market, with liberalized price control, grew by 16.7 % from 2015 to 2016. It is served by 28 companies which operate about 200 collection stations. There are 11 types of blood products of which human serum albumin is 54 %, human immunoglobulins 24 %. Factor VIII accounted for 6.3 % of blood products in 2016. Many more details are provided in the article.

China Bio news release, December 28, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny